Mile High Labs Opens State-Of-The-Art Facility

The CBD company recently opened its new 400,000-square-foot facility in Broomfield, CO. Photo by Mile High Labs

Mile High Labs recently opened its new 400,000-square-foot facility in Broomfield, CO. The large-scale CBD ingredient and product manufacturer purchased and closed on the facility on June 19, and the transaction included the land, labs, building, and ready-to-use finished products manufacturing equipment. The space was previously a pharmaceutical facility. The company produces private label products including tinctures, capsules, tablets, topicals, and gummies, and the facility includes equipment and infrastructure for research and development, quality assurance, bottling, filling, packing, warehousing, labeling, shipping, and compliance monitoring. “In light of recent legislative developments, the demand for our products has increased considerably,” says Stephen Mueller, chief technology officer and founder of Mile High Labs. “And it’s not just a domestic phenomenon. CBD is a global product and we serve a global customer base. This large-scale production facility will ensure we have the capacity to provide high quality, consistent CBD to every customer, large or small.”  


Purdue Receives USDA Grant To Study Organic Hemp Production

QAI Offers USDA Organic Certification For Hemp Crops And Products

Arthritis Foundation Releases First CBD Guidelines for Adults with Arthritis

Suggested Articles

Crown is now poised to become a global leader in dermatology health and wellness.

Belmond's new Good Living concept focuses on experiences that involve authentic and timeless interactions

Holly Cutler shares her expert thoughts on what to expect from medical spas in 2020.